Barbara Levi

Consigliere Generale presso UBS GROUP AG

Patrimonio netto: 2 M $ in data 31/07/2024

53 anni

99 relazioni

Consumer Services

Non-Energy Minerals

Health Technology

Profilo

Barbara Levi is currently the Director at the European General Counsel Association.
She also holds the position of Group General Counsel at UBS AG and UBS Group AG.
Additionally, she serves as a Member-Employees Board at King's College London.
Previously, she worked as the Group General Counsel at Rio Tinto Plc and Chief Legal, Governance & Ethics Officer at Rio Tinto Ltd.
Prior to that, she was the Global General Counsel at Sandoz International GmbH and Global Legal Head-Product Strategy at Novartis Pharma AG.
Ms. Levi holds a graduate degree from the University of Milan and a graduate degree from Fordham University School of Law.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
UBS GROUP AG 0.00%	31/12/2023	76 075 ( 0.00% )	2 M $	31/07/2024

Ultime notizie su Barbara Levi

Transcript : UBS Group AG - Shareholder/Analyst Call	24/04
UBS rimescola il management in vista del completamento della fusione con Credit Suisse	09/05/23	MT
UBS nomina il nuovo team di gestione mentre la fusione con Credit Suisse si avvicina alla conclusione legale	09/05/23	MT
Transcript : UBS Group AG - Shareholder/Analyst Call	05/04/23
Rio Tinto nomina AkzoNobel General Counsel come Chief Legal Officer	07/07/21	MT

Mostra altro

Posizioni attive di Barbara Levi

Società	Posizione	Inizio
UBS GROUP AG	Consigliere Generale	01/11/2021
UBS	Consigliere Generale	01/11/2021
European General Counsel Association	Direttore/Membro del Consiglio	-
King's College London	Corporate Officer/Principal	-

Tutte le posizioni attive di Barbara Levi

Precedenti posizioni note di Barbara Levi

Società	Posizione	Fine
RIO TINTO PLC	Public Communications Contact	25/10/2021
Sandoz International GmbH Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria.	Consigliere Generale	01/01/2019
RIO TINTO GROUP	Public Communications Contact	-
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.	Consigliere Generale	01/01/2013

Vedi nel dettaglio l'esperienza di Barbara Levi

Formazione di Barbara Levi

University of Milan	Graduate Degree
Fordham University School of Law	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Barbara Levi

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	3
RIO TINTO PLC	Non-Energy Minerals
RIO TINTO GROUP	Non-Energy Minerals
UBS GROUP AG	Finance

Aziende private	4
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.	Health Technology
UBS AG UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland.	Finance
European General Counsel Association
Sandoz International GmbH Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria.	Health Technology